Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces body weight mainly through loss of fat mass in subjects with type 2 diabetes S. Toubro,W. T. Cefalu,J. Xie,D. Sullivan, K. Usiskin,W. Canovatchel,G. MeiningerDIABETOLOGIA（2012）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
